Skip to Content
  • Rank15
  • Previous Rank14
  • CEO
    John H. Hammergren
  • Address
    1 Post St., San Francisco, CA 94104
  • Website
    www.mckesson.com

The nation’s largest drug distributor dropped one spot on this year’s list after a decline in warehouse sales resulted in a slight revenue dip. McKesson’s profits also slipped last year — down 4.6% to $1.3 billion — but the company hopes to improve its earnings and reach through its purchase of Germany’s Celesio, one of Europe’s top drug wholesalers. The company also recently drew the ire of activist investors upset over CEO John Hammergren’s record-setting $159 million pension benefit. The company leader responded to the complaints by agreeing to cut $45 million from the lump-sum compensation.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Key Financials

$ Millions% change
Revenues122,455-0.2
Profits
1338
-4.6
Total Assets34,786-
Total Shareholder Equity7,070-
Market Value (on March 31, 2014)40,633-

Profit as a % of

Sales1.1
Assets3.8
Stockholders' Equity18.9

Earnings Per Share

Earnings Per Share ($)5.59
EPS % Change (from 2012)-
EPS % Change (5 year)11
EPS % Change (10 year)11.5

Total Return to Investors

Total Return to Investors67.7
Total Return to Investors (5 year, annualized)34.3
Total Return to Investors (10 year, annualized)
18.4